Your browser doesn't support javascript.
Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis.
Rabaan, Ali A; Mutair, Abbas Al; Albayat, Hawra; Alotaibi, Jawaher; Sulaiman, Tarek; Aljeldah, Mohammed; Shammari, Basim R Al; Alfaraj, Amal H; Al Fares, Mona A; Alwarthan, Sara; Binjomah, Abdulwahab Z; Alzahrani, Mohammed S; Alhani, Hatem M; Almogbel, Mohammed S; Abuzaid, Abdulmonem A; Alqurainees, Ghaya; Al Ibrahim, Fatimah; Alhaddad, Ali H; Alfaresi, Mubarak; Al-Baghli, Nadira; Alhumaid, Saad.
  • Rabaan AA; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia.
  • Mutair AA; College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Albayat H; Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan.
  • Alotaibi J; Research Center, Almoosa Specialist Hospital, Al-Ahsa 36342, Saudi Arabia.
  • Sulaiman T; College of Nursing, Princess Norah bint Abdulrahman University, Riyadh 11564, Saudi Arabia.
  • Aljeldah M; School of Nursing, Wollongong University, Wollongong, NSW 2522, Australia.
  • Shammari BRA; Nursing Department, Prince Sultan Military College of Health Sciences, Dhahran 33048, Saudi Arabia.
  • Alfaraj AH; Infectious Disease Department, King Saud Medical City, Riyadh 7790, Saudi Arabia.
  • Al Fares MA; Infectious Diseases Unit, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia.
  • Alwarthan S; Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia.
  • Binjomah AZ; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39831, Saudi Arabia.
  • Alzahrani MS; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39831, Saudi Arabia.
  • Alhani HM; Pediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Abqaiq 33261, Saudi Arabia.
  • Almogbel MS; Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah 21589, Saudi Arabia.
  • Abuzaid AA; Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.
  • Alqurainees G; Microbiology Department, Riyadh Regional Laboratory and Blood Bank, Riyadh 12746, Saudi Arabia.
  • Al Ibrahim F; Department of Infectious Diseases, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah 21423, Saudi Arabia.
  • Alhaddad AH; Infectious Disease Department, King Saud Bin Abdulaziz University for Health Sciences, Jeddah 21423, Saudi Arabia.
  • Alfaresi M; Department of Pediatric Infectious Disease, Maternity and Children Hospital, Dammam 31176, Saudi Arabia.
  • Al-Baghli N; Department of Infection Control, Maternity and Children Hospital, Dammam 31176, Saudi Arabia.
  • Alhumaid S; Preventive Medicine and Infection Prevention and Control Department, Directorate of Ministry of Health, Dammam 32245, Saudi Arabia.
Molecules ; 27(20)2022 Oct 17.
Article in English | MEDLINE | ID: covidwho-2071654
ABSTRACT
Mycobacterium tuberculosis (Mtb), an acid-fast bacillus that causes Tuberculosis (TB), is a pathogen that caused 1.5 million deaths in 2020. As per WHO estimates, another 4.1 million people are suffering from latent TB, either asymptomatic or not diagnosed, and the frequency of drug resistance is increasing due to intrinsically linked factors from both host and bacterium. For instance, poor access to TB diagnosis and reduced treatment in the era of the COVID-19 pandemic has resulted in more TB deaths and an 18% reduction in newly diagnosed cases of TB. Additionally, the detection of Mtb isolates exhibiting resistance to multiple drugs (MDR, XDR, and TDR) has complicated the scenario in the pathogen's favour. Moreover, the conventional methods to detect drug resistance may miss mutations, making it challenging to decide on the treatment regimen. However, owing to collaborative initiatives, the last two decades have witnessed several advancements in both the detection methods and drug discovery against drug-resistant isolates. The majority of them belong to nucleic acid detection techniques. In this review, we highlight and summarize the molecular mechanism underlying drug resistance in Mtb, the recent advancements in resistance detection methods, and the newer drugs used against drug-resistant TB.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Nucleic Acids / COVID-19 / Mycobacterium tuberculosis Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Molecules27206985

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Nucleic Acids / COVID-19 / Mycobacterium tuberculosis Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal subject: Biology Year: 2022 Document Type: Article Affiliation country: Molecules27206985